Industry News (Meningitis Vaccine)

Meningitis Vaccine Produces Immunologic Memory after Single Toddler Dose

Published in Vaccine Weekly, October 11th, 1999

North American Vaccine is currently using its production facility to begin a manufacturing campaign of NeisVac-C, the company's group C meningococcal conjugate vaccine.

The United Kingdom has recently announced a mass group C meningococcal vaccination program that is expected to include NeisVac- C.

Dr. Peter Richmond of the U.K.'s Public Health Laboratory Service (PHLS) presented results of a comparative toddler clinical trial for group C meningococcal conjugate vaccines at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in San Francisco, California, held late September.

NeisVac-C elicited...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-10-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry